Professional Documents
Culture Documents
Module Antiparkinson
Module Antiparkinson
/var/www/apps/conversion/tmp/scratch_5/312216655.doc
Module
Antiparkinson
A. Learning Objective
(please refer to Competency Standard from Indonesian Medical Council / Konsil
Kedokteran Indonesia and Level of competency of epilepsy, appendix 1 and 2 ).
Level of Competency of
Parkinson's disease
Tremor
Secondary parkinsonism
Huntington disease
Chorea sydenham
Dystonia
Hemifacial spasm
3A
3A
3A
1
1
2
2
B.
Normal
Substansia
Nigra
Corpus
Striatum
Dopamine
Acethyl
choline
GABA
Parkinsonism
Substansia
Nigra
Corpus
Striatum
Dopamine
agonists
Dopamine
Acethyl
choline
GABA
Antimuscarinic
Drugs
Corpus
Striatum
Dopamine
Acethyl
choline
GABA
dopamine
DOPA decarboxylase
Inhibited by carbidopa
Potentiate dopamine effect
Adverse drug reaction : see ANS drug ( GIT effects, CV effects, dyskinesia
and behavioral effects )
b. Bromocriptine and other
1. Bromocriptine acts as a partial agonist at certain dopamine D 2 receptors in
the brain.
Clinical use : patients who are refractory to or cannot tolerate levodopa
Side Effects : dopamine like effects
c. Amantadine
Mechanisms : increasing synthesis and realese of dopamine by unknown
mechanisms.
Corpus
Striatum
Dopamine
Acethyl
choline
GABA
Parkinsonism
Substansia
Nigra
Corpus
Striatum
Dopamine
agonists
Dopamine
Acethyl
choline
GABA
Antimuscarinic
Drugs
Corpus
Striatum
Dopamine
Acethyl
choline
GABA